Augmenix Inc. announced the publication of the 222-patient pivotal study designed to evaluate safety and efficacy of the SpaceOAR System in men undergoing prostate radiotherapy. By creating space between the prostate and rectum, the SpaceOAR System is intended to reduce the radiation dose delivered to the rectum during prostate radiotherapy. The favorable results from the multi-center, randomized, single-blind study led to the April 1, 2015, U.S. Food and Drug Administration (FDA) clearance of the SpaceOAR System.

The American Society of Echocardiography (ASE) and Ke Labs jointly announced in May an agreement to co-develop and co-market a new cardiac ultrasound software application. The application is designed to ensure quality and consistency of cardiac ultrasound image review — both quantitatively and qualitatively — and inform and educate users on interesting cases, new techniques and other changes. This medical imaging quality management software tool is generally referred to as the “Echocardiography Test and Teach Application,” and it has been designed through the expert guidance of Harvey Feigenbaum, M.D., FASE with the Krannert Institute of Cardiology at Indiana University Health and founder of the ASE.

Epsilon Imaging Inc. announced that several studies were presented at the American Society of Echocardiography (ASE) 2015 conference, June 13-16, on its EchoInsight automated measurement suite for improved analysis and interpretation in echo.

On June 16, 2015, William Beaumont Hospital and Elekta Ltd. filed a patent infringement suit against Varian Medical Systems Inc. in the United States District Court for the Eastern District of Michigan.